Halozyme Therapeutics Inc (HALO)

[friendofthedevil]

"Halo needs cash now to get Peg to market, more than it will need a higher royalty in 7 years that may or may not happen. A bird in hand."

If PEG is that bird, you are a little more certain of its success than I am. I would rather see HALO hold out for high single digit royalties and leave the upfront and milestone payments alone. The way I see it, the Enhanze franchise is the bird in hand.

HALO should have enough cash and revenue growth now to get PEG through the current Ph2s. IMO, that is all they need.

But maybe the royalty rates ARE much better. If your speculation is that upfront payments have increased from 4 million per drug to 5 million, I really hope HALO is getting more money later in that drug's development. Enhanze should now be worth double what it was a few years ago.

As always, you having such facts at your fingertips is appreciated.